We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$10.9B
AUM Growth
+$1.02B
Cap. Flow
+$744M
Cap. Flow %
6.82%
Top 10 Hldgs %
30.62%
Holding
3,895
New
1,275
Increased
565
Reduced
595
Closed
1,134

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Healthcare 9.21%
3 Consumer Discretionary 8.28%
4 Industrials 6.28%
5 Materials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFIN
2051
DELISTED
BankFinancial
BFIN
$348K ﹤0.01%
+30,440
New +$326K
DOG
2052
ProShares Short Dow30
DOG
$97.5M
$348K ﹤0.01%
+10,223
New +$354K
VRRM icon
2053
Verra Mobility
VRRM
$778M
$347K ﹤0.01%
+22,633
New +$329K
XENE icon
2054
Xenon Pharmaceuticals
XENE
$6.24B
$347K ﹤0.01%
18,654
-2,224
-11% -$41K
ESQ icon
2055
Esquire Financial Holdings
ESQ
$1.14B
$346K ﹤0.01%
+14,600
New +$346K
RA
2056
Brookfield Real Assets Income Fund
RA
$706M
$346K ﹤0.01%
+15,821
New +$345K
ATRS
2057
DELISTED
Antares Pharma, Inc.
ATRS
$346K ﹤0.01%
+79,484
New +$324K
EML icon
2058
Eastern Company
EML
$151M
$345K ﹤0.01%
+11,380
New +$340K
IBCP icon
2059
Independent Bank Corp
IBCP
$793M
$345K ﹤0.01%
15,900
+201
+1% +$4.64K
YANG icon
2060
Direxion Daily FTSE China Bear 3X ETF
YANG
$90.8M
$345K ﹤0.01%
1,305
-540
-29% -$150K
INFY icon
2061
Infosys
INFY
$50.1B
$344K ﹤0.01%
16,239
-699
-4% -$13.4K
ARQ icon
2062
Arq
ARQ
$90.6M
$344K ﹤0.01%
+46,553
New +$287K
JSPR icon
2063
Jasper Therapeutics
JSPR
$21.5M
$343K ﹤0.01%
3,449
TCDA
2064
DELISTED
Tricida, Inc. Common Stock
TCDA
$343K ﹤0.01%
+79,530
New +$379K
MNTS icon
2065
Momentus
MNTS
$82.7M
$342K ﹤0.01%
2
-4
-67% -$584K
TIGR
2066
UP Fintech Holding
TIGR
$847M
$342K ﹤0.01%
11,816
-222,364
-95% -$4.73M
LDHAU
2067
DELISTED
LDH Growth Corp I Units
LDHAU
$341K ﹤0.01%
34,141
+2,072
+6% +$20.9K
TREB.U
2068
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
$341K ﹤0.01%
32,700
ONT
2069
Onterris Inc
ONT
$545M
$340K ﹤0.01%
+6,346
New +$334K
OTIS icon
2070
Otis Worldwide
OTIS
$28.1B
$339K ﹤0.01%
+4,151
New +$319K
NEBC
2071
DELISTED
Nebula Caravel Acquisition Corp. Class A Common Stock
NEBC
$339K ﹤0.01%
34,028
+3,507
+11% +$34.8K
QIWI
2072
DELISTED
QIWI PLC
QIWI
$339K ﹤0.01%
+31,882
New +$344K
ASMB icon
2073
Assembly Biosciences
ASMB
$524M
$337K ﹤0.01%
7,242
+4,619
+176% +$229K
BGS icon
2074
B&G Foods
BGS
$278M
$337K ﹤0.01%
+10,286
New +$317K
TRS icon
2075
TriMas Corp
TRS
$1.45B
$337K ﹤0.01%
11,141
-5,291
-32% -$168K

Similar funds

HRT Financial's Q2 2021 Portfolio in Review

As of Q2 2021, HRT Financial held 3,895 positions worth $10.9B, up 10% from $9.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HRT Financial deployed $744M of net new capital in Q2 2021, opening 1,275 new positions and adding to 565 existing holdings. Its largest new stake was Linde: 872,603 shares worth $252M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $330M trimmed.

  • HRT Financial's largest Q2 2021 buy was Linde: 872,603 shares worth $252M.
  • HRT Financial added most to Invesco QQQ Trust in Q2 2021, an estimated $289M increase.
  • HRT Financial's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $330M.
  • HRT Financial fully exited Palantir in Q2 2021, selling an estimated $130M.
  • HRT Financial's ten largest holdings make up 31% of its $10.9B portfolio in Q2 2021.
  • HRT Financial opened 1,275 new positions and closed 1,134 in Q2 2021.
  • HRT Financial's portfolio value rose 10% quarter-over-quarter to $10.9B.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.